MedPath

Influence of Respiratory Rate Settings on CO2 Levels During Nasal Intermittent Positive Pressure Ventilation (NIPPV).

Not Applicable
Completed
Conditions
Ventilator Lung; Newborn
Registration Number
NCT04836689
Lead Sponsor
Rambam Health Care Campus
Brief Summary

Infants will be monitored by TcCO2 during three consecutive time periods of one hour each on a high and low rate of NIPPV, when in a stable condition. NIPPV rate will start high/low, changed to low/high and switched back to starting rate.

Detailed Description

This will be a prospective, crossover observational study that will be performed at Rambam NICU.

Infants will be monitored by TcCO2 during three consecutive time periods of one hour each on a high and low rate of NIPPV, when in a stable condition.

NIPPV rate will start high/low, changed to low/high and switched back to starting rate.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Gestational age 240 to 336.
  • At least 6 hours of stabilized NIPPV settings, i.e. minor changes in settings (FiO2 ≤0.10, PIP≤ 2.0 cmH2O, RR≤ 5 brm).
  • At least 6 hours of stabilized tcCO2, i.e. ≤5 mmHg variation.
  • At least 6 hours from surfactant administration.
  • Parental consent
Exclusion Criteria
  • If NIPPV set rate is 10 bpm and tcCO2 related pCO2 is<40mmHg.
  • If NIPPV set rate is 30 bpm and tcCO2 related pCO2 is>60mmHg.
  • Unstable infants due to acute conditions (sepsis. IVH), or congenital malformations.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Trans cutaneous CO2 (TCCO2)During the 3 hours of the study

Trans cutaneous CO2

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rambam Medical Center

🇮🇱

Haifa, Israel

Rambam Medical Center
🇮🇱Haifa, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.